FDAnews Announces — New Management Report — Social Media Accountability for Drug and Devicemakers: Controlling the Online Conversation
Falls Church, VA (PRWEB) September 27, 2016 -- Social Media Accountability for Drug and Devicemakers:
Controlling the Online Conversation
**An FDAnews Management Report**
[http://info.fdanews.com/social-media-accountability-for-drug-and-devicemakers-vocus
Social media is a two-way street.
Manufacturers control the information they post. But, the audience can talk back and manufacturers can’t control what they say.
The FDA may not hold manufacturers responsible for reader comments, but they will watch for the way they respond.
If manufacturers want to use social media successfully and safely promote their products, they need to get inside the FDA’s head.
Social Media Accountability for Drug and Devicemakers gives manufacturers an understanding of how to use social media for product promotion without running afoul of the FDA:
• What online communications the FDA holds firms accountable for
• The differences between the FDA’s definitions of regulated and unregulated content and solicited and unsolicited communication
• How to present required risk information in limited space
• Correcting third-party misinformation
• When use of hyperlinks is appropriate
• Monitoring and reporting adverse events
Using social media to reach the audience can be very effective if manufacturers are creative and careful. Order the Social Media Accountability for Drug and Devicemakers management report today.
Who Will Benefit:
• Business managers
• Senior management
• Marketing staff
• Regulatory/legal affairs
• Communications department
FDAnews Management Report Details:
Social Media Accountability for Drug and Devicemakers:
Controlling the Online Conversation
Price: $397
[http://info.fdanews.com/social-media-accountability-for-drug-and-devicemakers-vocus
Easy Ways to Order:
Online: [http://info.fdanews.com/social-media-accountability-for-drug-and-devicemakers-vocus
By phone: 888-838-5578 or 703-538-7600
About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.
Michelle Butler, FDANEWS, http://www.fdanews.com, +1 (703) 538-7665, [email protected]
Share this article